![Scott Peters](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Scott Peters
Comptroller/Controller/Auditor bei PLIANT THERAPEUTICS, INC.
Aktive Positionen von Scott Peters
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
PLIANT THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 01.02.2021 | - |
Karriereverlauf von Scott Peters
Ehemalige bekannte Positionen von Scott Peters
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ALEXION PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 01.02.2017 | 01.02.2021 |
Direktor/Vorstandsmitglied | 01.07.2018 | 01.02.2021 |
Ausbildung von Scott Peters
University of California, Santa Barbara | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 4 |
Operativ
Comptroller/Controller/Auditor | 2 |
Director/Board Member | 1 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 3 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
PLIANT THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Alexion Pharmaceuticals, Inc.
![]() Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
- Börse
- Insiders
- Scott Peters
- Erfahrung